IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0258684.html
   My bibliography  Save this article

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease

Author

Listed:
  • Sebastian Cremer
  • Lisa Pilgram
  • Alexander Berkowitsch
  • Melanie Stecher
  • Siegbert Rieg
  • Mariana Shumliakivska
  • Denisa Bojkova
  • Julian Uwe Gabriel Wagner
  • Galip Servet Aslan
  • Christoph Spinner
  • Guillermo Luxán
  • Frank Hanses
  • Sebastian Dolff
  • Christiane Piepel
  • Clemens Ruppert
  • Andreas Guenther
  • Maria Madeleine Rüthrich
  • Jörg Janne Vehreschild
  • Kai Wille
  • Martina Haselberger
  • Hanno Heuzeroth
  • Arne Hansen
  • Thomas Eschenhagen
  • Jindrich Cinatl
  • Sandra Ciesek
  • Stefanie Dimmeler
  • Stefan Borgmann
  • Andreas Zeiher
  • on behalf of the LEOSS study group

Abstract

Aims: Patients with cardiovascular comorbidities have a significantly increased risk for a critical course of COVID-19. As the SARS-CoV2 virus enters cells via the angiotensin-converting enzyme receptor II (ACE2), drugs which interact with the renin angiotensin aldosterone system (RAAS) were suspected to influence disease severity. Methods and results: We analyzed 1946 consecutive patients with cardiovascular comorbidities or hypertension enrolled in one of the largest European COVID-19 registries, the Lean European Open Survey on SARS-CoV-2 (LEOSS) registry. Here, we show that angiotensin II receptor blocker intake is associated with decreased mortality in patients with COVID-19 [OR 0.75 (95% CI 0,59–0.96; p = 0.013)]. This effect was mainly driven by patients, who presented in an early phase of COVID-19 at baseline [OR 0,64 (95% CI 0,43–0,96; p = 0.029)]. Kaplan-Meier analysis revealed a significantly lower incidence of death in patients on an angiotensin receptor blocker (ARB) (n = 33/318;10,4%) compared to patients using an angiotensin-converting enzyme inhibitor (ACEi) (n = 60/348;17,2%) or patients who received neither an ACE-inhibitor nor an ARB at baseline in the uncomplicated phase (n = 90/466; 19,3%; p

Suggested Citation

  • Sebastian Cremer & Lisa Pilgram & Alexander Berkowitsch & Melanie Stecher & Siegbert Rieg & Mariana Shumliakivska & Denisa Bojkova & Julian Uwe Gabriel Wagner & Galip Servet Aslan & Christoph Spinner , 2021. "Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease," PLOS ONE, Public Library of Science, vol. 16(10), pages 1-17, October.
    • Handle: RePEc:plo:pone00:0258684
    DOI: 10.1371/journal.pone.0258684
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0258684
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0258684&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0258684?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Patrick J. Heagerty & Thomas Lumley & Margaret S. Pepe, 2000. "Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker," Biometrics, The International Biometric Society, vol. 56(2), pages 337-344, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Chin-Tsang Chiang & Shr-Yan Huang, 2009. "Estimation for the Optimal Combination of Markers without Modeling the Censoring Distribution," Biometrics, The International Biometric Society, vol. 65(1), pages 152-158, March.
    2. Te-Ling Ma & Tsung-Hui Hu & Chao-Hung Hung & Jing-Houng Wang & Sheng-Nan Lu & Chien-Hung Chen, 2019. "Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-16, October.
    3. Yingye Zheng & Patrick Heagerty, 2004. "Semiparametric Estimation of Time-Dependent: ROC Curves for Longitudinal Marker Data," UW Biostatistics Working Paper Series 1052, Berkeley Electronic Press.
    4. Shannon M Lynch & Elizabeth Handorf & Kristen A Sorice & Elizabeth Blackman & Lisa Bealin & Veda N Giri & Elias Obeid & Camille Ragin & Mary Daly, 2020. "The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-18, August.
    5. Weining Shen & Jing Ning & Ying Yuan, 2015. "A direct method to evaluate the time-dependent predictive accuracy for biomarkers," Biometrics, The International Biometric Society, vol. 71(2), pages 439-449, June.
    6. Si Cheng & Kathleen F Kerr & Heather Thiessen-Philbrook & Steven G Coca & Chirag R Parikh, 2020. "BioPETsurv: Methodology and open source software to evaluate biomarkers for prognostic enrichment of time-to-event clinical trials," PLOS ONE, Public Library of Science, vol. 15(9), pages 1-11, September.
    7. Lori E. Dodd, 2010. "ROC Curves for Continuous Data by KRZANOWSKI, W. J. and HAND, D. J," Biometrics, The International Biometric Society, vol. 66(2), pages 657-658, June.
    8. Yingye Zheng & Tianxi Cai & Ziding Feng, 2006. "Application of the Time-Dependent ROC Curves for Prognostic Accuracy with Multiple Biomarkers," Biometrics, The International Biometric Society, vol. 62(1), pages 279-287, March.
    9. C. Jason Liang & Patrick J. Heagerty, 2017. "Rejoinder to discussions on: A risk-based measure of time-varying prognostic discrimination for survival models," Biometrics, The International Biometric Society, vol. 73(3), pages 745-748, September.
    10. Ozcan, Erhan C. & Görgülü, Berk & Baydogan, Mustafa G., 2024. "Column generation-based prototype learning for optimizing area under the receiver operating characteristic curve," European Journal of Operational Research, Elsevier, vol. 314(1), pages 297-307.
    11. C. Jason Liang & Patrick J. Heagerty, 2017. "A risk-based measure of time-varying prognostic discrimination for survival models," Biometrics, The International Biometric Society, vol. 73(3), pages 725-734, September.
    12. Foucher Yohann & Danger Richard, 2012. "Time Dependent ROC Curves for the Estimation of True Prognostic Capacity of Microarray Data," Statistical Applications in Genetics and Molecular Biology, De Gruyter, vol. 11(6), pages 1-22, November.
    13. Yingye Zheng & Patrick J. Heagerty, 2007. "Prospective Accuracy for Longitudinal Markers," Biometrics, The International Biometric Society, vol. 63(2), pages 332-341, June.
    14. Jie Xiong & Zhitong Bing & Yanlin Su & Defeng Deng & Xiaoning Peng, 2014. "An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-8, May.
    15. Yingye Zheng & Patrick J. Heagerty, 2005. "Partly Conditional Survival Models for Longitudinal Data," Biometrics, The International Biometric Society, vol. 61(2), pages 379-391, June.
    16. Engler David & Li Yi, 2009. "Survival Analysis with High-Dimensional Covariates: An Application in Microarray Studies," Statistical Applications in Genetics and Molecular Biology, De Gruyter, vol. 8(1), pages 1-24, February.
    17. Patrick J. Heagerty & Yingye Zheng, 2005. "Survival Model Predictive Accuracy and ROC Curves," Biometrics, The International Biometric Society, vol. 61(1), pages 92-105, March.
    18. Tianxi Cai & Thomas A Gerds & Yingye Zheng & Jinbo Chen, 2011. "Robust Prediction of t-Year Survival with Data from Multiple Studies," Biometrics, The International Biometric Society, vol. 67(2), pages 436-444, June.
    19. Mogensen, Ulla B. & Ishwaran, Hemant & Gerds, Thomas A., 2012. "Evaluating Random Forests for Survival Analysis Using Prediction Error Curves," Journal of Statistical Software, Foundation for Open Access Statistics, vol. 50(i11).
    20. repec:plo:pone00:0086667 is not listed on IDEAS
    21. Mei-Cheng Wang & Shanshan Li, 2012. "Bivariate Marker Measurements and ROC Analysis," Biometrics, The International Biometric Society, vol. 68(4), pages 1207-1218, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0258684. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.